Clinical trial
7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced…
NCT00012194 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00012194 |
|---|---|
| Title | 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors |
| Official title | Phase I Dose Escalation Study of UCN-01 (NSC 638850) Plus Cisplatin in Advanced Malignant Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | 7-hydroxystaurosporine, cisplatin, laboratory biomarker analysis |
| Enrollment | 30 |
| Start date | Mar 1, 2001 |
| Primary completion | Jan 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: